A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells

Black, Roy A., Rauch, Charles T., Kozlosky, Carl J., Peschon, Jacques J., Slack, Jennifer L., Wolfson, Martin F., Castner, Beverly J., Stocking, Kim L. +12 more·1997·Nature
DOI 10.1038/385729a0

Cited by (1,007)

Items 101–200 of 1,007

  1. Effect of tumor microenvironment on pathogenesis of the head and neck squamous cell carcinoma: a systematic review
    Barbora Peltanová, Martina Raudenská, Michal Masařík · 2019 · Molecular Cancer
  2. Interleukin-18 and Interleukin-1β: Two Cytokine Substrates for ICE (Caspase-1)
    Giamila Fantuzzi, Charles Anthony Dinarello · 1999 · Journal of Clinical Immunology
  3. ADAMs: focus on the protease domain
    Roy A. Black, Judith M. White · 1998 · Current Opinion in Cell Biology
  4. Post-stroke inflammation—target or tool for therapy?
    Kate Lykke Lambertsen, Bente R. Finsen, Bettina Hjelm Clausen · 2018 · Acta Neuropathologica
  5. Prostaglandin E2 Regulates Cell Migration via the Intracellular Activation of the Epidermal Growth Factor Receptor
    F. Gregory Buchanan, Dingzhi Wang, Francesca Bargiacchi, Raymond N. DuBois · 2003 · Journal of Biological Chemistry
  6. Plasminogen activators, integrins, and the coordinated regulation of cell adhesion and migration
    Harold A. Chapman · 1997 · Current Opinion in Cell Biology
  7. Cell communication networks: epidermal growth factor receptor transactivation as the paradigm for interreceptor signal transmission
    Andreas Gschwind, Esther Zwick, Norbert Prenzel, Michael Leserer, Axel Ullrich · 2001 · Oncogene
  8. TIMPs: versatile extracellular regulators in cancer
    Hartland Warren Jackson, Virginie Defamie, Paul D. Waterhouse, Rama Khokha · 2016 · Nature reviews. Cancer
  9. Macrophage M1/M2 Polarization Dynamically Adapts to Changes in Cytokine Microenvironments in Cryptococcus neoformans Infection
    Michael J. Davis, Tiffany M. Tsang, Ya-Feng Qiu, Jeremy K. Dayrit, Joudeh B. Freij, G. Huffnagle, M. Olszewski · 2013 · mBio
  10. ADAMs family members as amyloid precursor protein α‐secretases
    Tobias M. J. Allinson, Edward T. Parkin, Anthony J. Turner, Nigel M. Hooper · 2003 · Journal of Neuroscience Research
  11. Cellular mechanisms of β-amyloid production and secretion
    Sukanto Sinha, Ivan M. Lieberburg · 1999 · Proceedings of the National Academy of Sciences
  12. Signal transduction by tumor necrosis factor receptors
    Lucía Cabal‐Hierro, Pedro S. Lazo · 2012 · Cellular Signalling
  13. The Transmembrane CXC-Chemokine Ligand 16 Is Induced by IFN-γ and TNF-α and Shed by the Activity of the Disintegrin-Like Metalloproteinase ADAM10
    Sören Abel, Christian Hundhausen, Rolf Mentlein, Alexander Schulte, Theo A. Berkhout, Neil M. BROADWAY, Dieter Hartmann, Radek Sedlacek, Sebastian Dietrich, Barbara Muetze et al. · 2004 · The Journal of Immunology
  14. Protease inhibitors of the sulfonamide type: Anticancer, antiinflammatory, and antiviral agents
    Claudiu Trandafir Supuran, Angela Casini, Andrea Scozzafava · 2003 · Medicinal Research Reviews
  15. Shedding of Syndecan-1 and -4 Ectodomains Is Regulated by Multiple Signaling Pathways and Mediated by a Timp-3–Sensitive Metalloproteinase
    Marilyn L. Fitzgerald, Zihua Wang, Pyong Woo Park, Gillian Murphy, Merton R. Bernfield · 2000 · The Journal of Cell Biology
  16. TREM2 in Neurodegenerative Diseases
    Jay, Taylor R., von Saucken, Victoria E., Landreth, Gary E. · 2017 · Molecular Neurodegeneration
  17. The metalloproteinase matrilysin proteolytically generates active soluble Fas ligand and potentiates epithelial cell apoptosis
    William C. Powell, Barbara Fingleton, Carole L. Wilson, Mark Robin Boothby, Lynn McCormick Matrisian · 1999 · Current Biology
  18. The “A Disintegrin And Metalloprotease” (ADAM) family of sheddases: Physiological and cellular functions
    Karina Reiß, Paul Säftig · 2008 · Seminars in Cell and Developmental Biology
  19. Metabolic Messengers: tumour necrosis factor
    Jaswinder K. Sethi, Gökhan S. Hotamışlıgil · 2021 · Nature Metabolism
  20. Aggrecanases and cartilage matrix degradation.
    Hideaki Nagase, Masahide Kashiwagi · 2003 · Arthritis Research
  21. ADAMs: modulators of cell–cell and cell–matrix interactions
    Judith M. White · 2003 · Current Opinion in Cell Biology
  22. ADAM-17: the enzyme that does it all
    Monika Beck Gooz · 2010 · Critical Reviews in Biochemistry and Molecular Biology
  23. Successful Applications of Computer Aided Drug Discovery: Moving Drugs from Concept to the Clinic
    Tanaji T. Talele, Santosh A. Khedkar, Alan C. Rigby · 2010 · Current Topics in Medicinal Chemistry
  24. Tumor Necrosis Factor-α Converting Enzyme (TACE) Regulates Epidermal Growth Factor Receptor Ligand Availability
    Susan W. Sunnarborg, C. Leann Hinkle, Mary C. Stevenson, William E. Russell, Christina S. Raska, Jacques J. Peschon, Beverly J. Castner, MARY J. GERHART, Raymond J. Paxton, Roy A. Black et al. · 2002 · Journal of Biological Chemistry
  25. TNFα in atherosclerosis, myocardial ischemia/reperfusion and heart failure
    Petra Kleinbongard, Gerd Heusch, Rainer Schulz · 2010 · Pharmacology & Therapeutics
  26. Evidence for a Role of a Tumor Necrosis Factor-α (TNF-α)-converting Enzyme-like Protease in Shedding of TRANCE, a TNF Family Member Involved in Osteoclastogenesis and Dendritic Cell Survival
    Lawrence Lum, Brian R. Wong, Régis Josien, J. David Becherer, Hediye Erdjument‐Bromage, Johannes S. Schlöndorff, Paul Tempst, Yongwon Choi, Carl Blobel · 1999 · Journal of Biological Chemistry
  27. Proteases and Proteolysis in Alzheimer Disease: A Multifactorial View on the Disease Process
    De Strooper, Bart · 2010 · Physiological Reviews
  28. The angiotensin–converting enzyme gene family: genomics and pharmacology
    Anthony J. Turner, Nigel M. Hooper · 2002 · Trends in Pharmacological Sciences
  29. Tumor Necrosis Factor Signaling Requires iRhom2 to Promote Trafficking and Activation of TACE
    Colin Adrain, Markus Zettl, Yonka Christova, Neil A. Taylor, Matthew Freeman · 2012 · Science
  30. Cytokines and Chemokines inMycobacterium tuberculosisInfection
    Racquel Domingo-Gonzalez, Oliver A. Prince, Andrea May Cooper, Shabaana A. Khader · 2016 · Microbiology Spectrum
  31. The in vitro activity of ADAM‐10 is inhibited by TIMP‐1 and TIMP‐3
    Augustin Amour, Christopher G. Knight, Ailsa Webster, Patrick M. Slocombe, Paul E. Stephens, Vera Knäuper, Andrew Docherty, Gillian Murphy · 2000 · FEBS Letters
  32. CD95(APO-1/Fas)-Mediated Apoptosis: Live and Let Die
    Peter H. Krammer · 1998 · Advances in immunology
  33. The macrophage response towards LPS and its control through the p38MAPK–STAT3 axis
    Johannes Georg Bode, Christian Ehlting, Dieter Häussinger · 2012 · Cellular Signalling
  34. Classical and Paradoxical Effects of TNF-α on Bone Homeostasis
    Bilal Osta, Giulia Benedetti, Pierre Miossec · 2014 · Frontiers in Immunology
  35. Disc in flames: Roles of TNF-α and IL-1β in intervertebral disc degeneration
    ZI Johnson, Zachary R. Schoepflin, Hyowon Choi, IM Shapiro, Makarand V. Risbud · 2015 · European Cells and Materials
  36. Crystal structure of the catalytic domain of human tumor necrosis factor-α-converting enzyme
    K. Maskos, Carlos Fernandez-Catalan, Robert Huber, Gleb P. Bourenkov, H.D. Bartunik, George A. Ellestad, Pranitha Reddy, Martin F. Wolfson, Charles T. Rauch, Beverly J. Castner et al. · 1998 · Proceedings of the National Academy of Sciences
  37. Tumor Necrosis Factor-α Mediates Cardiac Remodeling and Ventricular Dysfunction After Pressure Overload State
    Sun, Mei, Chen, Manyin, Dawood, Fayez, Zurawska, Urszula, Li, Jeff Y., Parker, Thomas, Kassiri, Zamaneh, Kirshenbaum, Lorrie A., Arnold, Malcolm, Khokha, Rama et al. · 2007 · Circulation
  38. Tumour necrosis factor signalling in health and disease
    Jonathan A. Holbrook, Samuel J Lara Reyna, Heledd Jarosz-Griffiths, Michael McDermott · 2019 · F1000Research
  39. The Biochemical, Biological, and Pathological Kaleidoscope of Cell Surface Substrates Processed by Matrix Metalloproteinases
    Bénédicte Cauwe, Philippe E. Van den Steen, Ghislain Opdenakker · 2007 · Critical Reviews in Biochemistry and Molecular Biology
  40. Neuroprotection and neurorescue against Aβ toxicity and PKC‐dependent release of non‐amyloidogenic soluble precursor protein by green tea polyphenol (‐)‐epigallocatechin‐3‐gallate
    Yona Levites, Tamar Amit, Silvia A. Mandel, Moussa B. H. Youdim · 2003 · The FASEB Journal
  41. Targeting Tumor Necrosis Factor Alpha for Alzheimer’s Disease
    Boris Decourt, Debomoy K. Lahiri, Marwan Noel Sabbagh · 2016 · Current Alzheimer Research
  42. Gallic acid: Molecular rival of cancer
    Sharad Verma, Amit Singh, Abha Mishra · 2013 · Environmental Toxicology and Pharmacology
  43. Cytokine storm in acute pancreatitis.
    Rohit Makhija, Andrew N. Kingsnorth · 2002 · Journal of Hepato-Biliary-Pancreatic Surgery
  44. The many faces of tumor necrosis factor in stroke
    Hallenbeck, John M. · 2002 · Nature Medicine
  45. Converting enzyme-independent release of tumor necrosis factor α and IL-1β from a stimulated human monocytic cell line in the presence of activated neutrophils or purified proteinase 3
    Claire M. Coeshott, Christie Ohnemus, Anna Pilyavskaya, Sherman Ross, Maciej Wieczorek, Heather Kroona, Axel H. Leimer, John C. Cheronis · 1999 · Proceedings of the National Academy of Sciences
  46. Matrix metalloproteinase-7–dependent release of tumor necrosis factor-α in a model of herniated disc resorption
    Hirotaka Haro, Howard C. Crawford, Barbara Fingleton, Kenichi Shinomiya, Dan M. Spengler, Lynn McCormick Matrisian · 2000 · Journal of Clinical Investigation
  47. Interleukin-6 expression and regulation in astrocytes
    Nicholas J. Van Wagoner, Etty N. Benveniste · 1999 · Journal of Neuroimmunology
  48. ADAMTS: a novel family of extracellular matrix proteases
    Bor Luen Tang · 2001 · The International Journal of Biochemistry & Cell Biology
  49. Intracellular maturation and localization of the tumour necrosis factor α convertase (TACE)
    Johannes S. Schlöndorff, J. David Becherer, Carl Blobel · 2000 · Biochemical Journal
  50. Metalloprotease-Disintegrins: Links to Cell Adhesion and Cleavage of TNFα and Notch
    Carl Blobel · 1997 · Cell
  51. The RANKL‐OPG system in clinical periodontology
    Georgios N. Belibasakis, Nagihan Bostancı · 2011 · Journal Of Clinical Periodontology
  52. In search of partners: linking extracellular proteases to substrates
    Christopher M. Overall, Carl Blobel · 2007 · Nature Reviews Molecular Cell Biology
  53. Drugs for Autoimmune Inflammatory Diseases: From Small Molecule Compounds to Anti-TNF Biologics
    Ping Li, Ying Zheng, Xin Chen · 2017 · Frontiers in Pharmacology
  54. Tumor necrosis factor-α converting enzyme
    Black, Roy A · 2002 · The International Journal of Biochemistry & Cell Biology
  55. Mechanisms for cytotoxic effects of anti–tumor necrosis factor agents on transmembrane tumor necrosis factor α–expressing cells: Comparison among infliximab, etanercept, and adalimumab
    Hiroki Mitoma, Takahiko Horiuchi, Hiroshi Tsukamoto, Yasuhiro Tamimoto, Yasutaka Kimoto, Ayumi Uchino, Kentaro To, Shin‐ichi Harashima, Nobuaki Hatta, Mine Harada · 2008 · Arthritis & Rheumatism
  56. Mouse glucocorticoid-induced tumor necrosis factor receptor ligand is costimulatory for T cells
    Masahide Tone, Yukiko Tone, Elizabeth Adams, Stephen F. Yates, Mark R. Frewin, Stephen Paul Cobbold, Herman Waldmann · 2003 · Proceedings of the National Academy of Sciences
  57. Proteolytic processing of Alzheimer’s β‐amyloid precursor protein
    Han Zhang, Qilin Ma, Yun‐wu Zhang, Huaxi Xu · 2011 · Journal of Neurochemistry
  58. Human Tumour Necrosis Factor: Physiological and Pathological Roles in Placenta and Endometrium
    Sandra Haider, Martin Knöfler · 2008 · Placenta
  59. Vascular endothelial cell growth factor is an autocrine promoter of abnormal localized immature myeloid precursors and leukemia progenitor formation in myelodysplastic syndromes
    William T. Bellamy, Lynne C. Richter, Davuud Sirjani, Concepcion Roxas, Betty Glinsmann‐Gibson, Yvette M. Frutiger, Thomas M. Grogan, Alan F. List · 2001 · Blood
  60. Structural aspects of the metzincin clan of metalloendopeptidases
    F. Xavier Gomis‐Rüth · 2003 · Molecular Biotechnology
  61. The shedding protease ADAM17: Physiology and pathophysiology
    Friederike Zunke, Stefan Rose‐John · 2017 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
  62. Mechanical loading, cartilage degradation, and arthritis
    Hui Bin Sun · 2010 · Annals of the New York Academy of Sciences
  63. The complex role of adipokines in obesity, inflammation, and autoimmunity
    Erin B. Taylor · 2021 · Clinical Science
  64. A soluble form of the Mer receptor tyrosine kinase inhibits macrophage clearance of apoptotic cells and platelet aggregation
    Susan Sather, Karla D. Kenyon, Jerry B. Lefkowitz, Xiayuan Liang, Brian C. Varnum, Peter M. Henson, Douglas K. Graham · 2006 · Blood
  65. Epithelial Cell Shedding and Barrier Function
    Jonathan M Williams, Carrie A. Duckworth, Michael David Burkitt, Alastair J.M. Watson, Barry James Campbell, David Mark Pritchard · 2014 · Veterinary Pathology
  66. A role for the phagosome in cytokine secretion
    Murray, Rachael Z., Kay, Jason G., Sangermani, Daniele G., Stow, Jennifer L. · 2005 · Science
  67. Matrix Metalloproteinase-3 Releases Active Heparin-binding EGF-like Growth Factor by Cleavage at a Specific Juxtamembrane Site
    Masashi Suzuki, Gerhard Raab, Marsha A. Moses, Cecilia A. Fernández, Michael Klagsbrun · 1997 · Journal of Biological Chemistry
  68. Tumor Necrosis Factor α and Nucleus-Pulposus-Induced Nerve Root Injury
    Kjell Olmarker, Karin Larsson · 1998 · Spine
  69. ADAMTS-1: a metalloproteinase-disintegrin essential for normal growth, fertility, and organ morphology and function
    Takayuki Shindo, Hiroki Kurihara, Kouji Kuno, Hitoshi Yokoyama, Takashi Wada, Yukiko Kurihara, Tomihiko Imai, Yuhui Wang, Masafumi Ogata, Hiroaki Nishimatsu et al. · 2000 · Journal of Clinical Investigation
  70. Protein Kinase C-dependent α-Secretase Competes with β-Secretase for Cleavage of Amyloid-β Precursor Protein in the Trans-Golgi Network
    Daniel Skovronsky, D.Blaine Moore, Marcos E. Milla, Robert W. Doms, Virginia M.‐Y. Lee · 2000 · Journal of Biological Chemistry
  71. IL-6 biology: implications for clinical targeting in rheumatic disease
    L. Calabrese, S. Rose-John · 2014 · Nature Reviews Rheumatology
  72. iRhom2 Regulation of TACE Controls TNF-Mediated Protection Against Listeria and Responses to LPS
    David R. McIlwain, Philipp Alexander Lang, Thorsten Maretzky, Koichi Hamada, Kazuhito Ohishi, Sathish Kumar Maney, Thorsten Berger, Aditya Murthy, Gordon S. Duncan, Haifeng C. Xu et al. · 2012 · Science
  73. Cellular Cholesterol Depletion Triggers Shedding of the Human Interleukin-6 Receptor by ADAM10 and ADAM17 (TACE)
    Matthews, Vance, Schuster, Björn, Schütze, Stefan, Bussmeyer, Ingo, Ludwig, Andreas, Hundhausen, Christian, Sadowski, Thorsten, Saftig, Paul, Hartmann, Dieter, Kallen, Karl-Josef et al. · 2003 · Journal of Biological Chemistry
  74. Angiotensin II induced proteolytic cleavage of myocardial ACE2 is mediated by TACE/ADAM-17: A positive feedback mechanism in the RAS
    Vaibhav B. Patel, Nicola E. Clarke, Zuocheng Wang, Fan Dong, Nirmal Parajuli, Ratnadeep Basu, Brendan Nicholas Putko, Zamaneh Kassiri, Anthony J. Turner, Gavin Y. Oudit · 2013 · Journal of Molecular and Cellular Cardiology
  75. Metalloprotease-Disintegrin MDC9: Intracellular Maturation and Catalytic Activity
    Monireh Roghani, J. David Becherer, Marcia L. Moss, Ruth E. Atherton, Hediye Erdjument‐Bromage, Joaquı́n Arribas, Kevin Blackburn, Gisela Weskamp, Paul Tempst, Carl Blobel · 1999 · Journal of Biological Chemistry
  76. Matrix Metalloproteinase-9 Is Necessary for the Regulation of Smooth Muscle Cell Replication and Migration After Arterial Injury
    Aesim Cho, Michael A. Reidy · 2002 · Circulation Research
  77. The Balance of TNF Mediated Pathways Regulates Inflammatory Cell Death Signaling in Healthy and Diseased Tissues
    Joshua D. Webster, Domagoj Vucic · 2020 · Frontiers in Cell and Developmental Biology
  78. Enzymatic toxins from snake venom: structural characterization and mechanism of catalysis
    Tse Siang Kang, Dessislava Nikolova Georgieva, Nicolay C. Genov, Mario Tyago Murakami, Mau Sinha, Ramasamy Prem Kumar, Punit Kaur, Sanjit Kumar, Sharmistha Dey, Sujata Sharma et al. · 2011 · FEBS Journal
  79. Reappraising metalloproteinases in rheumatoid arthritis and osteoarthritis: destruction or repair?
    Gillian Murphy, Hideaki Nagase · 2008 · Nature Clinical Practice Rheumatology
  80. Molecular mechanisms of action of anti-TNF-α agents – Comparison among therapeutic TNF-α antagonists
    Hiroki Mitoma, Takahiko Horiuchi, Hiroshi Tsukamoto, Naoyasu Ueda · 2016 · Cytokine
  81. A Novel, Secreted Form of Human ADAM 12 (Meltrin α) Provokes Myogenesis in Vivo
    Brent Gilpin, Frosty Loechel, Marie‐Geneviève Mattéi, Eva Engvall, Reidar Albrechtsen, Ulla M. Wewer · 1998 · Journal of Biological Chemistry
  82. A Common Functional Polymorphism (C->A Substitution at Position -863) in the Promoter Region of the Tumour Necrosis Factor- (TNF- ) Gene Associated With Reduced Circulating Levels of TNF-
    Tiina Skoog, Ferdinand M. van’t Hooft, Bengt Kallin, Stefan V. Jovinge, Susanna Boquist, Jan Nilsson, Per Olof Eriksson, Anders Hamsten · 1999 · Human Molecular Genetics
  83. Distinct roles for lymphotoxin‐α and tumor necrosis factor in organogenesis and spatial organization of lymphoid tissue
    Heinrich Körner, Matthew Cook, Sean Riminton, Frances A. Lemckert, Robert M. Hoek, Birgit Ledermann, Frank Köntgen, Barbara Fazekas de St Groth, Jonathon D. Sedgwick · 1997 · European Journal of Immunology
  84. Tumor Necrosis Factor-α-converting Enzyme Is Required for Cleavage of erbB4/HER4
    Carlos Río, Joseph D. Buxbaum, Jacques J. Peschon, Gabriel Corfas · 2000 · Journal of Biological Chemistry
  85. Extracellular Signal-regulated Kinase Phosphorylates Tumor Necrosis Factor α-converting Enzyme at Threonine 735: A Potential Role in Regulated Shedding
    Elena Dı́az-Rodrı́guez, Juan Carlos Montero, Azucena Esparı́s-Ogando, Laura Yuste, Atanasio Pandiella · 2002 · Molecular Biology of the Cell
  86. Proteolytic ectodomain shedding of membrane proteins in mammals—hardware, concepts, and recent developments
    Stefan F. Lichtenthaler, Marius K. Lemberg, Regina Fluhrer · 2018 · The EMBO Journal
  87. TNF Signaling in Vascular Endothelial Cells
    Lisa A. Madge, Jordan S. Pober · 2001 · Experimental and Molecular Pathology
  88. Ectodomain Shedding of Epidermal Growth Factor Receptor Ligands Is Required for Keratinocyte Migration in Cutaneous Wound Healing
    Sho Tokumaru, Shigeki Higashiyama, Takeshi Endo, Takatoshi Nakagawa, Jun‐ichiro Miyagawa, Katsumi Yamamori, Yasushi Hanakawa, Hiroshi Ohmoto, Kohichiro Yoshino, Yuji Shirakata et al. · 2000 · The Journal of Cell Biology
  89. Putative function of ADAM9, ADAM10, and ADAM17 as APP -secretase
    Masashi Asai, Chinatsu Hattori, Beáta Szabó, Noboru Sasagawa, Kei Maruyama, Sei-ichi Tanuma, Shoichi Ishiura · 2003 · Biochemical and Biophysical Research Communications
  90. Cutting Edge: TNF-α-Converting Enzyme (TACE/ADAM17) Inactivation in Mouse Myeloid Cells Prevents Lethality from Endotoxin Shock
    Keisuke Horiuchi, Tokuhiro Kimura, Takeshi Ken Miyamoto, Hironari Takaishi, Yasunori Okada, Yoshiaki Toyama, Carl Blobel · 2007 · The Journal of Immunology
  91. The role of cathepsins in osteoporosis and arthritis: Rationale for the design of new therapeutics
    Y YASUDA, J KALETA, Dieter Brömme · 2005 · Advanced Drug Delivery Reviews
  92. Shedding of the Mer Tyrosine Kinase Receptor Is Mediated by ADAM17 Protein through a Pathway Involving Reactive Oxygen Species, Protein Kinase Cδ, and p38 Mitogen-activated Protein Kinase (MAPK)
    Thorp, Edward, Vaisar, Tomas, Subramanian, Manikandan, Mautner, Lauren, Blobel, Carl, Tabas, Ira · 2011 · Journal of Biological Chemistry
  93. Ligands working as receptors: reverse signaling by members of the TNF superfamily enhance the plasticity of the immune system
    Günther Eißner, Walter Kölch, Peter Scheurich · 2004 · Cytokine & Growth Factor Reviews
  94. The role of TNF and its receptors in Alzheimer's disease
    Robert Perry · 2001 · Neurobiology of Aging
  95. Expression profiling of metalloproteinases and tissue inhibitors of metalloproteinases in normal and degenerate human achilles tendon
    Gavin C. Jones, Anthony N. Corps, Caroline J. Pennington, Ian M. Clark, Dylan R. Edwards, Michelle M. Bradley, Brian Leslie Hazleman, Graham P. Riley · 2006 · Arthritis & Rheumatism
  96. How tumour necrosis factor blockers interfere with tuberculosis immunity
    James Harris, Joseph Keane · 2010 · Clinical & Experimental Immunology
  97. The soluble Interleukin 6 receptor: Generation and role in inflammation and cancer
    Athena Chalaris, Christoph Garbers, Björn Rabe, Stefan Rose‐John, Jürgen Scheller · 2010 · European Journal of Cell Biology
  98. Acetylcholinesterase inhibitors: novel activities of old molecules
    Marco Racchi · 2004 · Pharmacological Research
  99. The Disintegrins ADAM10 and TACE Contribute to the Constitutive and Phorbol Ester-regulated Normal Cleavage of the Cellular Prion Protein
    Bruno Vincent, Erwan Paitel, Paul Säftig, Yveline Frobert, Dieter Hartmann, Bart De Strooper, Jacques J. Grassi, Elvira Lopez‐Perez, Frédéric Checler · 2001 · Journal of Biological Chemistry
  100. Role of Cytokines in Sepsis
    C. Erik Hack, Lucien A. Aarden, LAMBERTUS G. THUS · 1997 · Advances in immunology